Ubicación: Global + English
Global Global Algérie Français Algeria English Angola Português Angola English Argentina Español Argentina English Australia English Austria Deutsch Austria English Azerbaijan English Azerbaijan Русский Bahrain English Bangladesh English Belgium English Belgium Français Belgium Nederlands Brazil Português Brazil English Bulgaria български Bulgaria English Cameroon English Cameroon Français Canada English Canada Français Chile Español Chile English China 中文 China 日本語 China English Colombia Español Colombia English Croatia English Czech Republic Čeština Czech Republic English Denmark English Djibouti English Ecuador Español Ecuador English Egypt English Estonia English Ethiopia English Finland Suomi Finland English France Français France English Georgia English Georgia Русский Germany Deutsch Germany English Ghana English Greece Ελληνικά Greece English Guatemala Español Guatemala English Hong Kong, China English Hong Kong, China 中文 Hungary Magyar Hungary English India English Indonesia English Iraq English Ireland English Italy Italiano Italy English Ivory Coast Français Ivory Coast English Japan 日本語 Japan English Jordan English Kazakhstan Русский Kazakhstan English Kenya English Kuwait English Kyrgyzstan Русский Kyrgyzstan English Latvia English Lithuania English Malaysia English Mauritius English Mauritius français (Maurice) Mexico Español Mexico English Moldova Română Moldova English Mongolia English Morocco English Morocco Français Mozambique Português Mozambique English Netherlands Nederlands Netherlands English New Zealand English Nigeria English Norway English Oman English Pakistan English Paraguay Español Paraguay English Peru Español Peru English Philippines English Poland Polski Poland English Portugal Português Portugal English Qatar English Republic of Korea 한국어 Republic of Korea English Romania Română Romania English Saudi Arabia English Serbia Српски Serbia English Singapore English Slovakia English Slovenia English South Africa English Spain English Spain Español Sri Lanka English Sweden English Switzerland Deutsch Switzerland Français Switzerland Italiano Switzerland English Tanzania English Thailand ไทย Thailand English Togo English Togo Français Tunisia English Tunisia Français Türkiye Türkçe Türkiye English Turkmenistan Русский Turkmenistan English Ukraine Українська Ukraine English United Arab Emirates English United Kingdom English Uruguay Español Uruguay English USA English Uzbekistan English Uzbekistan Русский Vietnam Tiếng Việt Vietnam English

Indoor mosquito repellent efficacy testing is a controlled laboratory evaluation that quantifies how effectively household anti-mosquito products, such as mosquito coils, electric vaporizing mats, liquid vaporizers, aerosol sprays, and spatial repellent devices, knock down, kill, or repel mosquitoes under simulated residential conditions. Performed in accordance with recognized protocols such as the GB/T 13917 series, WHO guidance on spatial repellents, and US EPA product performance test guidelines, these tests generate the objective performance data required for product registration, quality control, and marketing claim substantiation. This article explains the technical scope, sample types, test parameters, methodologies, and evaluation criteria involved in indoor mosquito repellent efficacy testing.

Technical Overview

Indoor mosquito repellent efficacy testing is a standardized laboratory evaluation used to measure the biological performance of household insecticide and repellent products against mosquitoes in enclosed indoor environments. The core principle is to expose laboratory-reared, susceptible female mosquitoes to the test article inside a sealed glass chamber or a full-size test room, record knockdown at fixed time intervals, and hold the exposed insects for 24 hours to determine mortality. For products that act by preventing landing, probing, or biting rather than by intoxicating the insect, protection time and repellency rate are measured instead of, or in addition to, knockdown endpoints.

The principal methodological references include the GB/T 13917 national standard series on laboratory efficacy test methods and evaluation of public health insecticides, WHO guidelines for efficacy testing of spatial repellents, and the US EPA OPPTS 810.3700 product performance guideline for skin-applied insect repellents. Testing is typically conducted by accredited third-party laboratories or institutional insectaries that maintain standardized mosquito colonies and controlled environmental rooms.

  • Knockdown endpoints: KT50 and KT95 (median and 95% knockdown times)
  • Mortality endpoint: 24-hour corrected mortality rate
  • Repellency endpoints: repellency rate, landing inhibition, and complete protection time

Testing Samples

Mosquito Coils

Conventional coils, smoke-reduced coils, and coil refills are tested after ignition under standardized ventilation conditions. The test verifies both the burning behavior and the knockdown and mortality performance of the released active ingredient, typically a pyrethroid such as d-allethrin, prallethrin, or metofluthrin.

Electric Vaporizing Mats and Liquid Vaporizers

Electric mats (tablets) and liquid vaporizer refills, together with their dedicated heaters, are evaluated for vapor release, knockdown efficacy, and sustained protection. These products are often tested at multiple time points across their claimed usable life, such as after 4, 8, or 10 hours of continuous operation.

Aerosols and Trigger Sprays

Flying-insect aerosols and water-based pump sprays are tested by releasing a metered dose into the test chamber. The evaluation focuses on rapid knockdown, usually expressed as KT50 in minutes, and 24-hour mortality.

Spatial Repellent Devices

Battery-operated diffusers, fan-driven evaporators, passive emitters, botanical vapor devices, and similar non-combustion products are assessed for their ability to inhibit mosquito entry, landing, or host-seeking behavior within a defined treatment space.

Skin-Applied Repellents

Topical formulations containing active ingredients such as DEET, icaridin (picaridin), IR3535, or oil of lemon eucalyptus are evaluated for complete protection time against host-seeking mosquitoes using cage or room bioassay protocols.

Testing Items

Depending on the product category and the applicable standard, one or more of the following parameters are determined for each test article:

  • Knockdown rate at each scheduled observation interval
  • KT50 and KT95, calculated by probit or logit regression with 95% confidence limits
  • 24-hour mortality rate, corrected using Abbott's formula when control mortality falls between 5% and 20%
  • Repellency rate, calculated as R (%) = (C − T) / C × 100, where C and T are the numbers of landings or probings in the control and treatment groups
  • Complete protection time (CPT), defined as the period after application during which no confirmed mosquito landings or bites occur
  • Supplementary performance characteristics, such as burning time, active ingredient release profile, effective coverage volume, and performance consistency across production batches

Testing Methods

Test Insects

Testing is performed with susceptible reference strains reared under controlled insectary conditions, most commonly Aedes aegypti (yellow fever mosquito), Aedes albopictus (Asian tiger mosquito), Culex quinquefasciatus (southern house mosquito), and, where relevant, Anopheles species. Only non-blood-fed females aged approximately 3 to 7 days post-emergence are used. Each trial typically employs 50 to 100 mosquitoes per replicate, with a minimum of three valid replicates and a parallel unexposed control group.

Environmental Conditions

Testing is conducted in environmentally controlled rooms maintained at approximately 25 ± 2 °C with relative humidity of 60 ± 10%, under a defined photoperiod. Sugar feeding is suspended before exposure, and no food is provided during the test period, in line with the conditions specified by the applicable method.

Closed Chamber Method

The classic laboratory method uses a sealed cubic glass chamber of approximately 0.34 m³ (roughly 70 cm × 70 cm × 70 cm). The test article is introduced according to its label instructions: the coil is ignited, the mat or liquid heater is energized, or the spray dose is discharged. Caged mosquitoes are then released into the chamber, and knocked-down insects are counted at fixed intervals until the endpoint is reached. KT50 and KT95 are derived by probit analysis. Surviving mosquitoes are transferred to clean holding cages with sugar solution, and mortality is recorded 24 hours after exposure. A control chamber without treatment runs in parallel.

Test Room Method

For products intended to protect whole rooms, testing is performed in a full-size test room, commonly in the range of 10 to 30 m³, with free-flying mosquitoes. This method better reflects real residential use and is particularly suitable for vaporizing products with long-duration protection claims and for spatial repellent devices evaluated under WHO-style room protocols.

Protection Time and Repellency Assessment

Topical repellents and wearable devices are evaluated using arm-in-cage tests or excito-repellency chambers containing several hundred host-seeking females, following EPA product performance guidelines. The number of landings, probings, and bites is compared between treated and untreated surfaces to determine repellency rate and complete protection time. Human-subject protocols require prior ethical review and informed consent.

Data Evaluation and Grading

Knockdown data are analyzed by probit regression to obtain KT50 and KT95 with confidence intervals, and mortality data are corrected with Abbott's formula when justified. A test is considered invalid if control mortality exceeds 20%, and the trial must be repeated. Under the GB/T 13917 framework, results are graded A or B by product category: Grade A generally corresponds to very rapid knockdown and 24-hour mortality of 95% or higher, while Grade B thresholds are more lenient. The exact numeric limits are defined separately for coils, mats, liquids, and aerosols in the standard.

Applications

Indoor mosquito repellent efficacy testing serves multiple purposes across the product lifecycle:

  • Registration support: providing the mandatory efficacy data required for public health insecticide registration dossiers in national regulatory schemes
  • Product development: comparing formulations, active ingredients, synergists, and delivery systems during research and optimization
  • Quality control: verifying batch-to-batch consistency and release performance during commercial production
  • Claim substantiation: supporting marketing statements such as rapid knockdown, long-lasting protection, or protection for up to a stated number of hours
  • Export compliance: meeting buyer specifications and efficacy documentation requirements for international markets
  • Novel product verification: objectively evaluating emerging categories such as ultrasonic devices, botanical emitters, and wearable repellents

FAQ

What does KT50 mean and why is it important?

KT50 is the median knockdown time, the time required for 50% of the exposed mosquitoes to become knocked down. It is the primary indicator of how quickly a product takes effect. A short KT50 reflects fast action, which consumers perceive as immediate relief from mosquitoes, making it one of the most decisive grading criteria in indoor efficacy standards.

Which mosquito species are used in the tests?

The most common test species are Aedes aegypti and Aedes albopictus, supplemented by Culex quinquefasciatus and, where malaria-related claims are relevant, Anopheles species. All insects are laboratory-reared, susceptible, non-blood-fed females of a defined age to ensure reproducibility.

What results are required to pass the test?

Passing criteria depend on the product category and the applicable standard. Under the GB/T 13917 grading system, a Grade A result requires both a very fast KT50 and 24-hour mortality close to or above 95%, while Grade B accepts slower knockdown or lower mortality. For skin repellents, performance is judged by complete protection time in hours rather than by mortality.

Are human volunteers involved in the testing?

Only protection-time testing of skin-applied repellents involves human participants, and such studies require ethics committee approval, informed consent, and strict safety screening. Chamber and room efficacy tests for coils, vaporizers, and sprays are performed entirely with caged or free-flying insects and do not involve human subjects.

How long does a complete evaluation take?

A single chamber trial, including the 24-hour mortality observation, can be completed within one to two days. A full evaluation covering replicate trials, multiple time points, several product batches, data analysis, and reporting typically requires two to six weeks depending on the product type and test program scope.

Can ultrasonic or botanical devices be evaluated with these methods?

Yes. Non-chemical devices are assessed using room-scale or chamber-scale protocols in which mosquito flight activity, landing counts, and host-seeking behavior in the treatment space are compared with an untreated control. This provides objective, reproducible evidence of whether the device produces a measurable repellent effect.